Back
MBX Biosciences Vs. Bicara Therapeutics Industry Stock Comparison
Sell
28
MBX
MBX Biosciences
Last Price:
18.58
Seasonality Move:
--
Sell
20
BCAX
Bicara Therapeutics
Last Price:
18.08
Seasonality Move:
--
Sell
28
MBX Biosciences (MBX)
is a Sell
Is MBX Biosciences a Buy, Sell or Hold?
- The current MBX Biosciences [MBX] share price is $18.50. The Score for MBX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- MBX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
- The current Bicara Therapeutics [BCAX] share price is $18.09. The Score for BCAX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BCAX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MBX Stock Price Chart
What is MBX Biosciences's stock price today?
-
The MBX Biosciences share price today is $18.50
The current trend is relatively stagnant and MBX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $18.09
The current trend is relatively stagnant and BCAX is experiencing slight selling pressure.
MBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.58 | Sell |
| Relative Strength Index (14 RSI): | 41.37 | Sell |
| Chaikin Money Flow: | 70726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.44 - 23.66) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
BCAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 30.37 | Sell |
| Chaikin Money Flow: | -17151 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 24.31) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
MBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.7 | Buy |
| 20-day SMA: | 20.55 | Sell |
| 50-day SMA: | 22.17 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 18.08 | Buy |
| 20-day EMA: | 19.9 | Sell |
| 50-day EMA: | 3.6 | Buy |
| 200-day EMA: | 0.98 | Buy |
BCAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.65 | Sell |
| 20-day SMA: | 22.12 | Sell |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 19.51 | Sell |
| 20-day EMA: | 20.67 | Sell |
| 50-day EMA: | 17.42 | Buy |
| 200-day EMA: | 7.31 | Buy |
MBX Biosciences Earnings Growth & MBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $10.93 per share.
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.26 per share.
MBX Biosciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bicara Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||